The SARS-CoV-2 virus also depends on an enzyme, called Mpro, to replicate in host cells. Because cruzain and Mpro are ...
Research on the genome of the virus that causes severe acute respiratory syndrome (SARS) has revealed an unusual molecular structure that looks like a promising target for antiviral drugs. A team of ...
The global SARS outbreak lasted from late 2002 to mid-2003. During this time, over 8,000 people contracted the virus and 774 people died. The origin of SARS-CoV is thought to be bats. It’s believed ...
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for new broad-range antiviral medications. While many bacterial infections can be treated with the same medications, antiviral ...
Coronavirus disease 2019 (COVID-19) is a fatal respiratory illness caused by newly identified severe acute respiratory ...